Two members of the C3 Medical Review Network will be featured on the Diane Rehm Show on Thursday, July 17, 2008 discussing the high cost of cancer care.  They are scheduled for the 11 a.m. segment (Eastern time).

• John Marshall M.D. is Chief of Hematology/Oncology at the Lombardi Cancer Center at Georgetown University Hospital in Washington, D.C.  He is a specialist in gastrointestinal cancer.
• Neal Merepol M.D. directs the Gastrointestinal Cancer Center at Fox Chase Cancer Center in Philadephia.

They will be joined by Kevin LaMartina, American Cancer Society Patient Navigator at St. Agnes Hospital In Baltimore. Read the rest of this entry »

There’s nothing like the 4th of July to remind us of how great our country is. For me, what I love most about being an American is my right to speak out in support or opposition of what my elected officials are doing up in Congress and in the White House.

When I turned 18, I was so excited that I finally had the right to vote (you can imagine how much fun I was in high school). As a bona fide history geek, every time I vote, or place a call to Congress or write a letter to my electeds, I think about the patriots who embarked on a Great Experiment and sought to create a government of the people, by the people, for the people. How unsure they must have been that it would work, that a country without a strong central government would be able to thrive, that its citizens wouldn’t naturally gravitate back into living under tyranny. Ultimately, their faith in humankind won out over the fear and doubt. Man, that gets me.

Read the rest of this entry »

C3 will represent people touched by colorectal cancer with the Stand Up to Cancer (SU2C) initiative by serving on the SU2C Advocacy Advisory Council. “Our role as advocates is to help shape the direction of the exciting research that will be funded by SU2C,” said Nancy Roach, C3 Board of Directors.

SU2C is a national effort to raise substantial monies for ground-breaking translational cancer research that will accelerate advances in patient care as well as in cancer prevention.   A program of the Entertainment Industry Foundation, SU2C was established by a group of media, entertainment, and philanthropic leaders whose lives have all been affected by cancer in significant ways. They have partnered with American Association for Cancer Research (AACR) to provide expert scientific oversight of this important initiative.

The centerpiece of this initiative will be a nationally televised fundraising event to air on September 5, 2008.  The networks have joined together in an unprecedented collaboration to donate one hour of simultaneous, commercial-free prime time for this program.

Read the rest of this entry »

Welcome to our newly redesigned website!

More than just a fresh coat of paint, we’ve listened to your comments over the past 3 years and we’ve made the C3 site better than ever.

We hope you find the new site easier to navigate and search. You’ve come to rely on us for the most up-to-date research and treatment news, as well as the latest on what you can do to help us win the fight against colorectal cancer. That is not changing. In fact, we’ve made it easier than ever for you to subscribe to the latest site updates by RSS or email.

Be sure to explore the expanded Patient Information section. If there’s a particular term you’re looking for, you can now search our site from every page.

We’d like to thank Erik J. Barzeski and ACS (not that ACS) for their technical and design expertise which helped make this new site possible.

Please be patient with us as the site changes to the new look & feel. Let us know what you think (or any problems that you find) by leaving us a comment. We’d love to hear from you!

May has been set aside as National Cancer Research Month by Congressional resolutions in both the United States House of Representatives and United States Senate.

During May researchers, advocates, and patients are focusing on how far cancer research has brought us in preventing and treating cancer . . . and how far we have to go to end death and suffering from cancer. Read the rest of this entry »